-
Product Insights
Parasitology and Mycology Rapid Tests and POC Pipeline by Development Stages, Segments, Countries, Regulatory Path and Key Companies
Parasitology and Mycology Rapid Tests and POC Pipeline Market Report Overview Parasitology and mycology consist of rapid test kits. These are used for rapid diagnosis, with immediate results, through immunoassays for Plasmodium and Candida albicans. The Parasitology and Mycology Rapid Tests and POC pipeline market research report provides a comprehensive understanding of the pipeline products along with their comparative analysis at various stages of development. The report also includes information about the territories wherein the clinical trials are in progress,...
-
Product Insights
Cardiac Marker Tests Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies
Cardiac Marker Tests Pipeline Market Overview A cardiac marker test is a biomarker test used to diagnose cardiac diseases. The Cardiac Marker Tests pipeline market research report provides a comprehensive understanding of the pipeline products along with their comparative analysis at various stages of development. The report also includes information about the territories wherein the clinical trials are in progress, the regulatory paths followed by the trials, and the companies associated with the trials. Key Segments ·       Other Cardiac Marker...
-
Analyst Opinions
Digging Deeper into Sustainability – Key Disruptive Forces in Mining (Vol.3)
Disruptive Forces in Mining Report Overview The demand for cleaner and more sustainable energy solutions such as flow batteries is rising owing to growing ESG pressure. Flow batteries have emerged as a promising technology that can contribute to a more reliable and environmentally friendly energy landscape. Leading players as well as startups are investing in developing sustainable solutions. For instance, the new kind of sodium batteries, being developed by startups such as Finland-based Broadbit and India-based AR4 Tech offer much...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Tofacitinib Citrate in Systemic-Onset Juvenile Idiopathic Arthritis (Still Disease)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Tofacitinib Citrate in Systemic-Onset Juvenile Idiopathic Arthritis (Still Disease) report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Tofacitinib Citrate in Systemic-Onset Juvenile Idiopathic Arthritis...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Tofacitinib Citrate in Hidradenitis Suppurativa
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Tofacitinib Citrate in Hidradenitis Suppurativa report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Tofacitinib Citrate in Hidradenitis Suppurativa Drug Details: Tofacitinib (Xeljanz, Jaquinus) is...
-
Sector Analysis
Urinary Tract Stents Market Size by Segments, Share, Regulatory, Reimbursement, Procedures and Forecast to 2033
Urinary Tract Stents Market Report Overview The urinary tract stents market size was $206.1 million in 2023. The market will grow at a CAGR of more than 4% during 2023-2033. A urinary tract stent is a small tube either composed of metal or polymer material, which is inserted into the urinary tract to maintain luminal patency of the tract. Urinary Tract Stents Market Outlook, 2023-2033 ($ Million) Â Buy the Full Report for More Insights into the Urinary Tract Stents Market...
-
Sector Analysis
Contract Pharmaceutical Dose Manufacturing Industry – Composition, Size, Market Share and Outlook, 2023 Edition
Contract Pharmaceutical Dose Manufacturing Industry Overview The total dose CMO contract revenue in 2022 represented significant growth over 2021 revenue. The growth rate was the highest recorded since 2011 for commercial contract dose manufacturing revenues, and surprisingly adds to the strong growth experienced in 2021, despite demand for COVID-19 vaccines and therapies waning in 2022. The Contract Pharmaceutical Dose Manufacturing Industry report is a comprehensive look at the finished dose contract manufacturing landscape in 2023. It includes an analysis of...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Tofacitinib Citrate in Systemic Idiopathic Juvenile Arthritis
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. Tofacitinib Citrate in Systemic Idiopathic Juvenile Arthritis Drug Details: Tofacitinib (Xeljanz, Jaquinus) is an immunosuppressant....
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Tofacitinib Citrate in Chronic Granulomatous Disease
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Tofacitinib Citrate in Chronic Granulomatous Disease report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data.Tofacitinib Citrate in Chronic Granulomatous DiseaseDrug Details: Tofacitinib (Xeljanz, Jaquinus) is...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Minocycline in Acne Vulgaris
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Minocycline in Acne Vulgaris report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data.Minocycline in Acne VulgarisDrug Details:Minocycline (BPX-01) is under development for the treatment of...